Chronic pain affects more than 50 million Americans, yet for decades, treatment options for pain that persists in the absence ...
Researchers have identified OTULIN, an immune-regulating enzyme, as a key trigger of tau buildup in the brain. When OTULIN ...
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) ...
Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University led have uncovered ...
Pediatric acute myeloid leukemia (AML) is one of the most common acute leukemias in children. While treatment outcomes have ...
Tanabe Pharma America, Inc., the wholly owned subsidiary of Tanabe Pharma Corporation, today announced positive topline efficacy and safety results from the global Phase 3 clinical trial, also known ...
Global Heparin Market OverviewThe global heparin market is projected to expand at a steady compound annual growth rate of around 5% through 2031, supported by the rising burden of chronic and ...
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) ...
Researchers from The University of Osaka reveal that genetic changes following the loss of heterochromatin can lead to ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
Stocktwits on MSN
Why is Cadrenal Therapeutics stock drawing retail attention today?
The company outlined progress on its anticoagulation pipeline, including its HIT program VLX-1005, at a Lytham Partners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback